Cassel Shapiro - Profile and Investment Details

Investor Profile

Cassel Shapiro is a Corporate Venture Capital based in United States with a diverse investment portfolio that includes companies such as GlobeImmune, Orchestra BioMed, Armada Water Assets, Motus GI, Helocyte, Outstanding Foods, Hydrofarm, Adgero Biopharmaceuticals, Deem, BackBeat Medical, Organovo Holdings, Kintara Therapeutics, Caliber Therapeutics, PROLOR Biotech, DarioHealth, InVivo Therapeutics, Corbus Pharmaceuticals, MATINAS BIOPHARMA, Aerami Therapeutics. Over time, Cassel Shapiro has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Cassel Shapiro is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Consumer Goods, Food Processing, Wholesale, Biotech, Cloud Computing, Diabetes, Hydroponics, Medical Device, Software, Manufacturing, Healthcare, Biotechnology, AgTech, Nutrition, Food and Beverage, Agriculture, Farming, Snack Food, Medical, Therapeutics, Packaged Goods may find it worthwhile to explore potential connections with Cassel Shapiro, as their portfolio suggests a familiarity and interest in this area.

Understanding Cassel Shapiro’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.